Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer.
Clinical trial NCT03467178 · UNKNOWN
Trial details
- NCT number
- NCT03467178
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-30
- Primary completion
- 2021-12-01
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.